Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) investigators. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk - Eikelboom, JW (Circulation, 2008)